Neurogene (NGNE) Invested Capital (2013 - 2025)
Neurogene (NGNE) posted Invested Capital of $19000.0 for Q4 2025, down 76.25% on a QoQ basis from $80000.0 in Q4 2024, and down 76.25% year-over-year from $80000.0 in Q4 2024.
Neurogene (NGNE) Invested Capital (2013 - 2025) Analysis & Trends
Neurogene's Invested Capital history runs 8 years deep, the most recent figure standing at $19000.0 for Q4 2025.
- Quarterly Invested Capital fell 76.25% year-over-year to $19000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $19000.0 (down 93.17% YoY) and the FY2025 annual result came in at $19000.0, down 76.25% from the prior year.
- Invested Capital was $19000.0 for Q4 2025 at Neurogene, down from $80000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $122000.0 in Q4 2021 and bottomed at $19000.0 in Q4 2025.
- A 5-year average of $89000.0 and a median of $94500.0 in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital climbed 18.89% — and 2025, when it slumped 76.25%.
- Neurogene's Invested Capital stood at $122000.0 in 2021, then decreased by 26.23% to $90000.0 in 2022, then increased by 18.89% to $107000.0 in 2023, then retreated by 25.23% to $80000.0 in 2024, then slumped by 76.25% to $19000.0 in 2025.
- Business Quant data shows NGNE's Invested Capital at $19000.0 in Q4 2025, $80000.0 in Q4 2024, and $93000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 93,000.00 |
| Jun 30, 2024 | 105,000.00 |
| Mar 31, 2024 | 96,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Dec 31, 2022 | 90,000.00 |
| Dec 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 157,000.00 |
| Dec 31, 2019 | 208,000.00 |
| Sep 30, 2019 | 211,000.00 |
| Dec 31, 2013 | 250,000.00 |